SARS-CoV-2 Testicular Lipid Metabolism Replication
- For many, COVID-19 presents as a respiratory illness.However, emerging research reveals a more complex picture, with the virus capable of impacting multiple organ systems - including the male...
- The study, published in Frontiers in Cellular and Infection Microbiology and supported by FAPESP, utilized transgenic mice engineered to express the human ACE2 receptor - the entry point...
- SARS-CoV-2 exploits the Leydig cells' existing metabolic pathways, particularly those involving cholesterol - a vital building block for testosterone. The virus essentially redirects cholesterol from hormone synthesis towards...
Published August 21, 2025
The Virus’s Unexpected Target
For many, COVID-19 presents as a respiratory illness.However, emerging research reveals a more complex picture, with the virus capable of impacting multiple organ systems – including the male reproductive system. A recent study conducted by researchers at the Araraquara School of Dentistry at São Paulo State University (FOAr-UNESP) and the Ribeirão Preto School of Medicine at the University of São Paulo (FMRP-USP) has uncovered a surprising mechanism: SARS-CoV-2 directly infects testicular cells responsible for testosterone production.
Hijacking the Testosterone-Making Machinery
The study, published in Frontiers in Cellular and Infection Microbiology and supported by FAPESP, utilized transgenic mice engineered to express the human ACE2 receptor – the entry point for the virus. Researchers observed that SARS-CoV-2 particles actively invade Leydig cells, the primary testosterone-producing cells within the testes. Crucially, the virus doesn’t just passively infect these cells; it actively commandeers their internal processes.
SARS-CoV-2 exploits the Leydig cells’ existing metabolic pathways, particularly those involving cholesterol – a vital building block for testosterone. The virus essentially redirects cholesterol from hormone synthesis towards viral replication, effectively shutting down testosterone production to fuel its own spread. Researchers confirmed this process occurs in both the transgenic mice and, importantly, in human testicular tissue.
A Two-Pronged Attack: Replication and Immune Response
The impact isn’t limited to simply diverting resources. The research team found that infected Leydig cells undergo a functional shift. Not only do they cease normal testosterone production, but they also begin to exhibit an immunological profile, releasing large amounts of pro-inflammatory cytokines. As Psalm Azambuja de Oliveira, the study’s frist author, explained, “Infection with SARS-CoV-2 also induced the Leydig cells to produce large amounts of pro-inflammatory cytokines, a process they don’t normally perform. This increase in cytokines may also have interfered with testosterone production, impairing this main function.”
This dual action – suppressing hormone production and triggering inflammation – creates a potentially damaging cycle within the testes.
why This Matters: Men’s health and COVID-19
These findings offer a compelling description for clinical observations linking severe COVID-19 to lower testosterone and cholesterol levels in men. This hormonal disruption may contribute to the observed increased vulnerability and higher mortality rates among male patients. The concentration of the ACE2 receptor in leydig cells makes them particularly susceptible to infection, potentially explaining why the testes are a target organ for the virus.
future Directions: Therapies and Biomarkers
The study’s findings open doors for the development of new diagnostic tools and therapeutic strategies. Researchers suggest that monitoring testosterone and cholesterol levels could serve as biomarkers to assess the severity of COVID-19 infection. Furthermore, exploring lipid-lowering drugs that interfere with viral replication and lipid metabolism may offer a potential avenue for treatment.
As Estela sasso-Cerri,the study coordinator,noted,the results “pave the way for developing markers that indicate the severity of COVID-19,as well as therapies for treating the disease based on[[[[lipid-lowering]drugs that interfere with lipid metabolism and inhibit viral action.”
